Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more
Cosmos Health Inc. (COSM) - Net Assets
Latest net assets as of September 2025: $23.13 Million USD
Based on the latest financial reports, Cosmos Health Inc. (COSM) has net assets worth $23.13 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($69.49 Million) and total liabilities ($46.36 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $23.13 Million |
| % of Total Assets | 33.29% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 374.87 |
Cosmos Health Inc. - Net Assets Trend (2010–2024)
This chart illustrates how Cosmos Health Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cosmos Health Inc. (2010–2024)
The table below shows the annual net assets of Cosmos Health Inc. from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $24.53 Million | -31.93% |
| 2023-12-31 | $36.04 Million | -9.11% |
| 2022-12-31 | $39.66 Million | +805.52% |
| 2021-12-31 | $4.38 Million | +205.25% |
| 2020-12-31 | $-4.16 Million | +35.60% |
| 2019-12-31 | $-6.46 Million | -94.75% |
| 2018-12-31 | $-3.32 Million | -9.56% |
| 2017-12-31 | $-3.03 Million | -72.74% |
| 2016-12-31 | $-1.75 Million | -40.47% |
| 2015-12-31 | $-1.25 Million | -122.80% |
| 2014-12-31 | $5.47 Million | +10296.00% |
| 2013-12-31 | $-53.68K | -3838.66% |
| 2012-12-31 | $-1.36K | +71.38% |
| 2011-12-31 | $-4.76K | +72.76% |
| 2010-12-31 | $-17.48K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cosmos Health Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11402227500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $23.69K | 0.10% |
| Other Comprehensive Income | $-2.13 Million | -8.70% |
| Other Components | $140.67 Million | 573.38% |
| Total Equity | $24.53 Million | 100.00% |
Cosmos Health Inc. Competitors by Market Cap
The table below lists competitors of Cosmos Health Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Taiwan Advanced Nanotech Inc.
TWO:6797
|
$8.90 Million |
|
Chromocell Therapeutics Corporation
NYSE MKT:CHRO
|
$8.90 Million |
|
JCBNext Berhad Bhd
KLSE:0058
|
$8.91 Million |
|
artnet AG
PINK:ARTZF
|
$8.91 Million |
|
Artha Optimum A/S
CO:ARAOPT
|
$8.90 Million |
|
EAST STAR RES.PLC LS-01
F:5MM
|
$8.90 Million |
|
FORIS AG
F:FRS
|
$8.90 Million |
|
NFL Biosciences SAS
PA:ALNFL
|
$8.90 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cosmos Health Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 36,043,028 to 24,532,929, a change of -11,510,099 (-31.9%).
- Net loss of 16,183,018 reduced equity.
- Dividend payments of 6,195,024 reduced retained earnings.
- Share repurchases of 100,452 reduced equity.
- New share issuances of 649,039 increased equity.
- Other comprehensive income decreased equity by 2,134,931.
- Other factors increased equity by 12,454,287.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-16.18 Million | -65.96% |
| Dividends Paid | $6.20 Million | -25.25% |
| Share Repurchases | $100.45K | -0.41% |
| Share Issuances | $649.04K | +2.65% |
| Other Comprehensive Income | $-2.13 Million | -8.7% |
| Other Changes | $12.45 Million | +50.77% |
| Total Change | $- | -31.93% |
Book Value vs Market Value Analysis
This analysis compares Cosmos Health Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.27x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $-0.06 | $0.35 | x |
| 2010-12-31 | $-0.21 | $0.35 | x |
| 2011-12-31 | $-0.05 | $0.35 | x |
| 2012-12-31 | $-0.01 | $0.35 | x |
| 2013-12-31 | $-0.13 | $0.35 | x |
| 2014-12-31 | $10.88 | $0.35 | x |
| 2015-12-31 | $-2.48 | $0.35 | x |
| 2016-12-31 | $-3.49 | $0.35 | x |
| 2017-12-31 | $-5.92 | $0.35 | x |
| 2018-12-31 | $-6.23 | $0.35 | x |
| 2019-12-31 | $-12.17 | $0.35 | x |
| 2020-12-31 | $-7.82 | $0.35 | x |
| 2021-12-31 | $6.67 | $0.35 | x |
| 2022-12-31 | $20.57 | $0.35 | x |
| 2023-12-31 | $2.27 | $0.35 | x |
| 2024-12-31 | $1.28 | $0.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cosmos Health Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -65.96%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29.73%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 2.21x
- Recent ROE (-65.96%) is below the historical average (-13.98%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.14K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.79 Million |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-168.77K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-314.70 |
| 2013 | 0.00% | 27.33% | 1.04x | 0.00x | $251.96K |
| 2014 | 110.43% | 79.13% | 1.06x | 1.32x | $5.50 Million |
| 2015 | 0.00% | -1252.88% | 0.81x | 0.00x | $-6.56 Million |
| 2016 | 0.00% | -8.90% | 2.17x | 0.00x | $-425.72K |
| 2017 | 0.00% | -20.69% | 2.81x | 0.00x | $-5.91 Million |
| 2018 | 0.00% | -24.43% | 1.79x | 0.00x | $-8.73 Million |
| 2019 | 0.00% | -8.31% | 1.66x | 0.00x | $-2.65 Million |
| 2020 | 0.00% | 1.48% | 1.26x | 0.00x | $1.24 Million |
| 2021 | -181.80% | -14.16% | 1.14x | 11.29x | $-8.40 Million |
| 2022 | -34.88% | -27.47% | 0.74x | 1.72x | $-17.80 Million |
| 2023 | -51.45% | -34.74% | 0.81x | 1.83x | $-22.15 Million |
| 2024 | -65.96% | -29.73% | 1.00x | 2.21x | $-18.64 Million |
Industry Comparison
This section compares Cosmos Health Inc.'s net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,390,032,324
- Average return on equity (ROE) among peers: 1.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cosmos Health Inc. (COSM) | $23.13 Million | 0.00% | 2.00x | $8.90 Million |
| Accendra Health Inc (ACH) | $314.40 Million | 8.91% | 1.75x | $22.90K |
| Arjo AB (publ) (ARRJF) | $6.88 Billion | 10.78% | 1.12x | $491.29 Million |
| Cardinal Health Inc (CAH) | $255.60 Million | 13.15% | 1.57x | $50.81 Billion |
| Cencora Inc. (COR) | $4.01 Billion | 11.02% | 2.01x | $62.31 Billion |
| EDAP TMS SA (EDAP) | $50.05 Million | 1.40% | 0.54x | $115.72 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-362.21K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-84.27 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $999.54 Million | 12.50% | 1.21x | $3.75 Billion |